Related Experiment Video
Updated: Aug 30, 2025
11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.5K
Non-coding RNA in rhabdomyosarcoma progression and metastasis
Farah Ramadan1,2,3,4, Raya Saab5,6, Nader Hussein4
1Department of Biology, Faculty of Science II, Lebanese University, Beirut, Lebanon.
Frontiers in Oncology
|August 29, 2022
Summary
Non-coding RNAs (ncRNAs) play crucial roles in rhabdomyosarcoma (RMS) development and progression. Understanding these ncRNAs offers potential for improved RMS prognosis and novel therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Rhabdomyosarcoma (RMS) is a pediatric soft tissue sarcoma often presenting with metastatic disease, particularly the aggressive fusion-positive subtype.
- Non-coding RNAs (ncRNAs) regulate gene expression and are implicated in cancer development and progression.
- Aberrant expression of microRNAs (miRNAs), long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), and ribosomal RNAs (rRNAs) is linked to RMS biology.
Purpose of the Study:
- To review the established roles of ncRNAs in RMS differentiation, growth, and progression.
- To highlight the potential of ncRNAs in RMS prognosis and as therapeutic targets or agents.
Main Methods:
- Literature review of studies investigating ncRNA involvement in rhabdomyosarcoma.
- Analysis of established and emerging roles of various ncRNA classes (miRNA, lncRNA, circRNA, rRNA) in RMS.
Main Results:
- ncRNAs are integral to RMS biology, influencing differentiation, growth, and progression.
- Dysregulation of specific ncRNAs is associated with RMS initiation and advancement.
- Further research is needed to fully elucidate the mechanistic roles of certain ncRNAs in RMS.
Conclusions:
- ncRNAs represent a significant area of investigation for understanding RMS pathogenesis.
- ncRNAs hold promise as biomarkers for RMS prognosis.
- Targeting ncRNAs may offer novel therapeutic avenues for rhabdomyosarcoma treatment.
More Related Videos
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.5K
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.9K
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
8.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.8K
01:03Rous Sarcoma Virus (RSV) and Cancer
5.3K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.3K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:22MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
01:13Formation of Muscle Fibers from Myoblasts
5.1K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.1K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K